MM

Megha Mitulkumar Panchal

Active Director Director DIN 11025333
DIN 11025333 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Megha Mitulkumar Panchal

Data last updated:

Megha Mitulkumar Panchal is a Director at Nebtas Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11025333
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20252025Active

Board colleagues of Megha Mitulkumar Panchal

NameDINCompanyDesignation
Chanda Sonubabu Thakur11025332Nebtas Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nebtas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Megha Mitulkumar Panchal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Megha Mitulkumar Panchal

Megha Mitulkumar Panchal currently holds 1 directorship: Nebtas Pharmaceuticals Private Limited (Director, since 28 Mar 2025).

Megha Mitulkumar Panchal was first appointed on 28 Mar 2025 as Director at Nebtas Pharmaceuticals Private Limited.

The current boards of Megha Mitulkumar Panchal's companies include Chanda Sonubabu Thakur (Nebtas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available